| Citation: |
ZHANG Ning, ZHANG Xiaochen, HE Mu, SUN Xiaohong, KANG Lin, QU Xuan, ZHU Minglei. A Bibliometric Analysis of the Global Research on Multimorbidity in Older Adults from 2000 to 2023[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 867-876. DOI: 10.12290/xhyxzz.2023-0516
|
To analyze the research trends and cutting-edge hot spots in the field of multimorbidity in older adults from 2000 to 2023 to provide reference for related research.
We conducted a search in the Web of Science Core Collection database, specifically looking for articles or reviews in English on multimorbidity in older adults published between January 1, 2000 and October 24, 2023. VOSviewer 1.6.18 software was used to extract the contents in the literature and draw the cooperative network diagram of high-producing countries(≥30 articles) and institutions(≥43 articles) as well as the timeline diagram of high-frequency keywords(≥74 occurrences) co-occurrence relationship. CiteSpace 6.1.R6 software was used to co-occur and cluster analyze the information of authors, research institutions and countries. The "bibliometrix" package in R was used to analyze the evolution of keywords in the literature.
A total of 2590 documents consisting of 2230 Articles and 360 Reviews were obtained. The worldwide publication count significantly increased since 2000. Among the countries, the United States had the highest number of publications (35.02%, 907/2590) and total citations(31 343 times) in this field. The University of Toronto in Canada had the largest number of articles(2.59%, 67/2590). Jenny Ploeg of McMaster University was recognized as the most prolific author(1.24%, 32/2590). When it came to journals, BMC Geriatrics had the highest amount of literature related to multimorbidity(3.82%, 99/2590). The key areas of research in this field included multimorbidity, older adults, frailty, aging, and polypharmacy. Notably, there was growing interest in studying the relationship between multimorbidity and aging in older adults, as well as the impact of frailty and polypharmacy on multimorbidities.
In recent years, research on multimorbidities in the elderly has primarily centered around examining the correlation between comorbidities and aging, as well as exploring the impact of frailty and polypharmacy on individuals with multimorbidities. Future research could delve into primary health care, comprehensive geriatric assessment for older adults with multimorbidities, and maintenance of their overall quality of life.
| [1] |
闫伟, 路云, 张冉, 等. 基于CHARLS数据分析的我国老年人共病现状研究[J]. 中华疾病控制杂志, 2019, 23(4): 426-430. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ201904013.htm
Yan W, Lu Y, Zhang R, et al. Multimorbidity status of the elderly in China-research based on CHARLS data[J]. Chin J Dis Control Prev, 2019, 23(4): 426-430. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ201904013.htm
|
| [2] |
Xu X L, Mishra G D, Jones M. Evidence on multimorbidity from definition to intervention: an overview of systematic reviews[J]. Ageing Res Rev, 2017, 37: 53-68. DOI: 10.1016/j.arr.2017.05.003
|
| [3] |
Kivimäki M, Strandberg T, Pentti J, et al. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study[J]. Lancet Diabetes Endocrinol, 2022, 10(4): 253-263. DOI: 10.1016/S2213-8587(22)00033-X
|
| [4] |
The Emerging Risk Factors Collaboration. Association of cardiometabolic multimorbidity with mortality[J]. JAMA, 2015, 314(1): 52-60. DOI: 10.1001/jama.2015.7008
|
| [5] |
Vetrano D L, Rizzuto D, Calderón-Larra aga A, et al. Trajectories of functional decline in older adults with neuropsychiatric and cardiovascular multimorbidity: a Swedish cohort study[J]. PLoS Med, 2018, 15(3): e1002503. DOI: 10.1371/journal.pmed.1002503
|
| [6] |
王丽敏, 陈志华, 张梅, 等. 中国老年人群慢性病患病状况和疾病负担研究[J]. 中华流行病学杂志, 2019, 40(3): 277-283.
Wang L M, Chen Z H, Zhang M, et al. Study of the prevalence and disease burden of chronic disease in the elderly in China[J]. Chin J Epidemiol, 2019, 40(3): 277-283.
|
| [7] |
La D T V, Zhao Y, Arokiasamy P, et al. Multimorbidity and out-of-pocket expenditure for medicines in China and India[J]. BMJ Glob Health, 2022, 7(11): e007724. DOI: 10.1136/bmjgh-2021-007724
|
| [8] |
Muth C, Blom J W, Smith S M, et al. Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus[J]. J Intern Med, 2019, 285(3): 272-288. DOI: 10.1111/joim.12842
|
| [9] |
Liu W M, Wu J Y, Zhang N, et al. Postural deformities in Parkinson's disease: a bibliometric analysis based on web of science[J]. Heliyon, 2023, 9(3): e14251. DOI: 10.1016/j.heliyon.2023.e14251
|
| [10] |
Van Eck N J, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping[J]. Scientometrics, 2010, 84(2): 523-538. DOI: 10.1007/s11192-009-0146-3
|
| [11] |
Zhou J, Song D, Ma J J, et al. Research trends in the mental health and multimorbidity of older people from 2002 to 2022: a bibliometric analysis via CiteSpace[J]. Front Psychiatry, 2023, 14: 1117554. DOI: 10.3389/fpsyt.2023.1117554
|
| [12] |
Wang L Y, Luo D, Hamdaoui O, et al. Bibliometric analysis and literature review of ultrasound-assisted degradation of organic pollutants[J]. Sci Total Environ, 2023, 876: 162551. DOI: 10.1016/j.scitotenv.2023.162551
|
| [13] |
Ye B Q, Xie R X, Mishra S R, et al. Bidirectional association between physical multimorbidity and subclinical depression in Chinese older adults: findings from a prospective cohort study[J]. J Affect Disord, 2022, 296: 169-174. DOI: 10.1016/j.jad.2021.09.067
|
| [14] |
Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys[J]. Lancet, 2007, 370(9590): 851-858. DOI: 10.1016/S0140-6736(07)61415-9
|
| [15] |
Triolo F, Sjöberg L, Calderón-Larrañaga A, et al. Late-life depression and multimorbidity trajectories: the role of symptom complexity and severity[J]. Age Ageing, 2023, 52(2): afac315. DOI: 10.1093/ageing/afac315
|
| [16] |
Kroenke K, Strine T W, Spitzer R L, et al. The PHQ-8 as a measure of current depression in the general population[J]. J Affect Disord, 2009, 114(1/3): 163-173.
|
| [17] |
Marengoni A, Angleman S, Melis R, et al. Aging with multimorbidity: a systematic review of the literature[J]. Ageing Res Rev, 2011, 10(4): 430-439. DOI: 10.1016/j.arr.2011.03.003
|
| [18] |
Schiltz N K. Prevalence of multimorbidity combinations and their association with medical costs and poor health: a population-based study of U.S. adults[J]. Front Public Health, 2022, 10: 953886. DOI: 10.3389/fpubh.2022.953886
|
| [19] |
Li H F, Chang E X, Zheng W J, et al. Multimorbidity and catastrophic health expenditure: evidence from the China Health and Retirement Longitudinal Study[J]. Front Public Health, 2022, 10: 1043189. DOI: 10.3389/fpubh.2022.1043189
|
| [20] |
Guo X R, Zhao B H, Chen T M, et al. Multimorbidity in the elderly in China based on the China Health and Retirement Longitudinal Study[J]. PLoS One, 2021, 16(8): e0255908. DOI: 10.1371/journal.pone.0255908
|
| [21] |
Zheng D D, Loewenstein D A, Christ S L, et al. Multimorbidity patterns and their relationship to mortality in the US older adult population[J]. PLoS One, 2021, 16(1): e0245053. DOI: 10.1371/journal.pone.0245053
|
| [22] |
American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians[J]. J Am Geriatr Soc, 2012, 60(10): E1-E25.
|
| [23] |
Boyd C, Smith C D, Masoudi F A, et al. Decision making for older adults with multiple chronic conditions: executive summary for the American Geriatrics Society guiding principles on the care of older adults with multimorbidity[J]. J Am Geriatr Soc, 2019, 67(4): 665-673. DOI: 10.1111/jgs.15809
|
| [24] |
Fraser H C, Kuan V, Johnen R, et al. Biological mechanisms of aging predict age-related disease co-occurrence in patients[J]. Aging Cell, 2022, 21(4): e13524. DOI: 10.1111/acel.13524
|
| [25] |
Salvioli S, Basile M S, Bencivenga L, et al. Biomarkers of aging in frailty and age-associated disorders: state of the art and future perspective[J]. Ageing Res Rev, 2023, 91: 102044. DOI: 10.1016/j.arr.2023.102044
|
| [26] |
Luo Y, Chen Y M, Wang K P, et al. Associations between multimorbidity and frailty transitions among older Americans[J]. J Cachexia Sarcopenia Muscle, 2023, 14(2): 1075-1082. DOI: 10.1002/jcsm.13197
|
| [27] |
Hanlon P, Nicholl B I, Jani B D, et al. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants[J]. Lancet Public Health, 2018, 3(7): e323-e332. DOI: 10.1016/S2468-2667(18)30091-4
|
| [28] |
Lipska K J, Krumholz H, Soones T, et al. Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 diabetes[J]. JAMA, 2016, 315(10): 1034-1045. DOI: 10.1001/jama.2016.0299
|
| [29] |
陈旭娇, 严静, 王建业, 等. 老年综合评估技术应用中国专家共识[J]. 中华老年医学杂志, 2017, 36(5): 471-477. https://www.cnki.com.cn/Article/CJFDTOTAL-LNBY201702001.htm
Chen X J, Yan J, Wang J Y, et al. Chinese experts consensus on application of comprehensive geriatric assessment[J]. Chin J Geriatr, 2017, 36(5): 471-477. https://www.cnki.com.cn/Article/CJFDTOTAL-LNBY201702001.htm
|
| 1. |
卢月，任晓蕾，吴晶晶，黎莉，危建安，韩凌，卢传坚. 中医湿邪与自身免疫性疾病复发的相关性探讨. 广州中医药大学学报. 2025(04): 1007-1012 .
| |
| 2. |
杨湘君，周玮，王丽，魏晓晨. 白细胞介素抑制剂与肿瘤坏死因子-α抑制剂治疗银屑病的有效性及安全性比较的Meta分析. 临床皮肤科杂志. 2024(03): 161-164 .
| |
| 3. |
刘小琨，张苍，王翊同. 基于生物信息学分析银屑病基因表达差异及潜在中药. 中医学报. 2024(03): 643-649 .
| |
| 4. |
邓琪，毛一斌，项彤，谢意杰，黄群. 司库奇尤单抗治疗成人中重度斑块状银屑病的效果及复发的相关因素分析. 现代实用医学. 2024(02): 209-211 .
| |
| 5. |
陈梦学，叶文珍，姚赐玉，张婧. 司库奇尤单抗治疗成人中重度斑块状银屑病的疗效及复发的相关因素分析. 齐齐哈尔医学院学报. 2024(06): 544-547 .
| |
| 6. |
李敏，杜红阳. 多种不良生活方式导致银屑病发生的孟德尔随机化研究. 锦州医科大学学报. 2024(05): 82-86 .
| |
| 7. |
马文欣，刘世巍，孟祥飞，韩佳童，高梦琦，姜昱如. 基于《金匮要略》“阳毒”理论辨治病毒性肺炎诱发银屑病. 中国中医基础医学杂志. 2024(12): 2125-2127 .
| |
| 8. |
路霞，马春梅，庞娟娟. 银屑病住院患者生活质量与负性情绪的相关性分析. 宁夏医学杂志. 2023(03): 278-282 .
| |
| 9. |
赵月纯，张玉衡，李佳琦，罗逸祺，董芮，宋坪. 基于“一气周流”理论探讨“升肝降肺”在银屑病辨治中的应用. 环球中医药. 2023(04): 747-750 .
| |
| 10. |
刘琨. 生地土茯苓汤联合卡泊三醇软膏治疗寻常型银屑病临床研究. 河南中医. 2023(08): 1213-1216 .
| |
| 11. |
刘明晶，宋业强. 宋业强教授运用湿热清治疗皮肤病经验. 中国中医药现代远程教育. 2023(19): 52-54 .
| |
| 12. |
张中华，闫小宁，黄雪英，吴迪. 银屑病中医药动物模型的研究进展. 河北中医. 2023(11): 1916-1919 .
| |
| 13. |
张宁，张琼，杨素清，安月鹏. 银屑病与糖尿病共病的中医研究进展. 中国医药导报. 2023(30): 47-50 .
| |
| 14. |
支炳伟，于叶，唐叶，吴科佳，谭城. 祛屑止痒方对头皮银屑病(血虚风燥型)的临床研究. 中华中医药学刊. 2023(12): 78-81 .
| |
| 15. |
欧敏，林秀球，邱晓愉，袁立燕，余晓玲，杨斌，王晓华. 移动医疗APP对管理生物制剂治疗银屑病的效果. 皮肤性病诊疗学杂志. 2022(05): 429-433 .
| |
| 16. |
李雯，周涛，姜春燕，姜希，苏婕，蔡一歌，赵子赫，程皓洋，江雅楠，李玉梅，周冬梅. 中医药治疗司库奇尤单抗致银屑病加重2例. 北京中医药. 2022(10): 1187-1190 .
| |
| 17. |
王俞涵，祝梦媛，文礼智，朱世豪，曾佳. 本维莫德乳膏治疗轻中度斑块型银屑病疗效和安全性分析. 农垦医学. 2022(05): 423-426 .
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: